Both elevated STAT5a and STAT5b mRNA expression are associated with a favorable OS for all the ovarian cancer patients (STAT5a: P=0.036, Figure 5A; STAT5b: P=0.028, Figure 6A). This evidence concerns the gene STAT5A and ovarian cancer.